Author: John Bellich

John Bellich is a managing director and senior research analyst at Tech Insider, specializing in networking technologies, including application traffic management, networking equipment, 3D printing and video conferencing sectors. Prior to joining TI in 2005, John spent seven years in equity research at ThinkEquity Partners and RBC Capital Markets.
FB Nasdaq FB Facebook
Diversified Tech, Internet, Mobile

Diversified Communication: BlackBerry Ltd (NASDAQ:BBRY), Glowpoint (NYSEMKT:GLOW), GTT Communications (NYSEMKT:GTT), B Communications (NASDAQ:BCOM)

BlackBerry Ltd (NASDAQ:BBRY) is planning to launch its recently unveiled low-cost smartphone, the Z3, in Indonesia first, which is  a promising market. BlackBerry Ltd (NASDAQ:BBRY) stock performance was -4.67% in last session and finished the day at $10.00. Traded volume was 6,025.00 shares in the last session and the average volume of the stock remained 29.26 million shares. The beta of the stock remained 1.70. … Continue reading Diversified Communication: BlackBerry Ltd (NASDAQ:BBRY), Glowpoint (NYSEMKT:GLOW), GTT Communications (NYSEMKT:GTT), B Communications (NASDAQ:BCOM)

John Bellich
BioTech

Biotech Bearish Stocks: Questcor Pharmaceuticals (NASDAQ:QCOR), ACADIA Pharmaceuticals (NASDAQ:ACAD), Idera Pharmaceuticals (NASDAQ:IDRA), Celldex Therapeutics (NASDAQ:CLDX)

Citron exposes explosive findings behind the true components of Questcor Pharmaceuticals Inc (NASDAQ:QCOR) flagship drug HP Acthar Gel. Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) stock performance was -9.96% in last session and finished the day at $60.75. Traded volume was 0.00 shares in the last session and the average volume of the stock remained 2.86 million shares. The beta of the stock remained 0.95. Questcor Pharmaceuticals Inc. … Continue reading Biotech Bearish Stocks: Questcor Pharmaceuticals (NASDAQ:QCOR), ACADIA Pharmaceuticals (NASDAQ:ACAD), Idera Pharmaceuticals (NASDAQ:IDRA), Celldex Therapeutics (NASDAQ:CLDX)

John Bellich
Software

Street Expecting $.06 EPS, Revenue of $1.12B from Salesforce.com (NYSE:CRM) in Quarter

Salesforce.com (NYSE:CRM) is set to report its Q4 results in tonight’s after-hours. Analysts polled by Capital IQ expect earnings of $0.06 per share on revenue of $1.12 billion. CRM favors a reversal trend between the bells following its after-hours earnings reports, narrowing or reversing 19 times and widening 18 times in next-day trade following its last 37 extended-hours earnings reports. Looking deeper into the performance … Continue reading Street Expecting $.06 EPS, Revenue of $1.12B from Salesforce.com (NYSE:CRM) in Quarter

John Bellich
Analysis, Earnings

Chart Industries, Inc. Weak Guidance Highlights Q4 Results

Chart Industries’ (NASDAQ:GTLS) overall fourth quarter 2013 EPS and awards were mostly in line with expectations; however, we believe this will be overshadowed by lower-than-expected 2014 EPS guidance ($3.10-$3.50 versus consensus $3.67) and more subdued market commentary regarding near-term growth prospects. There was already a somewhat downward bias to 2014 consensus EPS, the more cautious market commentary about near-term growth prospects may come as a … Continue reading Chart Industries, Inc. Weak Guidance Highlights Q4 Results

John Bellich
Finance, Software

After Hours Earnings Roundup – KOS, TXRH, RP, WGMI, SCTY, FI, SF

Kosmos Energy (NYSE:KOS) is higher after the oil exploration and production company reported that for Q4, its earnings were in line while revenue topped Street forecasts. Shares are up 2.73% at $10.91, with a 52-week range of $9.71 – $12.17. KOS said Q4 net income fell to $0.01 from $0.08 a year ago, in line with analysts’ estimates, according to Capital IQ. Total revenue was … Continue reading After Hours Earnings Roundup – KOS, TXRH, RP, WGMI, SCTY, FI, SF

John Bellich
Diversified Tech, Semiconductors

RealD Inc. Posts Strong Fiscal Third Quarter Results

RealD reported strong fiscal third-quarter results; revenue and profitability came in ahead of expectations. Total revenue of $55.4 million was above the consensus estimate of $50.4 million and adjusted EBITDA of $21.3 million were well above the consensus estimate of $15.2 million. Licensing revenue of $35.6 million was above the consensus estimate of $34.2 million, and product revenue of $19.8 million was above consensus of … Continue reading RealD Inc. Posts Strong Fiscal Third Quarter Results

John Bellich